The 411 before 911 on USP 797: Changes, Challenges, and Choices

Posted on November 30, 2023
Moderator and panelists

Moderator:
Katrina K. Harper, PharmD, MBA, BCSCP, DPLA
Director of Clinical Education,
AIS Healthcare

Panelists:
Anita Abata, PharmD, BCPS, BCCCP, BCSCP
Sterile Compounding Coordinator/Hazardous
Drug Designated Person, John Peter Smith
Inpatient Pharmacy/Oncology and Infusion Center

Kirk Starr, MBA, RPh
System Director, Pharmacy Operations & Special
Programs, Baylor Scott & White Health

Ehigie Garvey Omorodion, PharmD, BCSCP, BCNSP, CNSC, CPPS
Pharmacy Manager IV Sterile
Products/Oncology, Parkland Health & Hospital System

Paul Menasco, PharmD
System Accreditation and Regulatory
Compliance Pharmacist, Ochsner Health

Cindy Polk Dumas, RPh, PharmD
Vice President of Pharmacy Services –TDD, AIS Healthcare

Disclosure (s):
The moderator, panelists, and the reviewers who contributed to this activity have no relevant financial conflicts of interest to disclose.

 

Acknowledgements: This CE presentation is supported by an unrestricted educational grant from AIS Healthcare.

Type of Activity: Knowledge-based

Learning Objectives:

  • State the new compounded sterile preparation (CSP) category definitions
  • List the requirements for the updated beyond-use dates (BUDs) for each CSP category
  • Summarize the additional requirements for entities that compound Category 3 CSPs
  • Discuss significant changes that will impact pharmacy operations
Target Audience: Pharmacists Fee: Free
Release Date: November 30, 2023 Expiration Date: November 30, 2025
Estimated time to complete: 1.5 hours CE: 1.5 contact hours (0.15 CEUs)

Go to activity

ACPE logo
The University of Illinois Chicago College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. The non-accredited cosponsor for this activity is the National Association of Specialty Pharmacy (NASP). This activity has been assigned an ACPE Universal Activity Number 0016-9999-23-170-H07-P for 1.5 contact hours (0.15 CEUs). Attendance at the entire knowledge-based activity, completion of the post-test and electronic pharmacist evaluation, and submission of NABP eProfile ID and MMDD are prerequisites for receiving continuing pharmacy education credit(s). All ACPE credit awarded to participants must be uploaded to CPE Monitor ™ within 30 days of the activity date, so pharmacists are required to provide their e-Profile ID and date of birth (MMDD) at the time of the activity. Please contact pharmce@uic.edu if you do not see the activity information listed within 30 days. For more information and to set up your e-Profile visit: www.MyCPEmonitor.net

How to Earn Credit:

Participants must complete the activity as described above in the Continuing Education Statement. To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on ‘Finish Attempt’, then click on ‘Submit All and Finish’ at the bottom of the page. Your post-test will automatically be graded. If you successfully complete the post-test, a confirmation message will appear at the top of the page underneath your grade. You will have a chance to review the correct answers and answer rationale. After completing the post-test, you will proceed to the activity evaluation to claim your CE credit. All CE credits will be uploaded to CPE Monitor ™.

Hardware/Software and Internet Requirements can be found at https://pharmacyce.uic.edu/moodle/.

Provider Contact Information:
For general information or questions,  email the Office of Continuing Education and Meeting Services at pharmce@uic.edu. Copyright © 2023– The Board of Trustees of the University of Illinois. All rights reserved. Reproduction in whole or in part without permission is prohibited. Privacy Policy

NASP Disclaimer: The Specialty Pharmacy Certification Board (SPCB) develops and oversees certification programs for specialty pharmacists and licensed pharmacists who work in a capacity related to specialty pharmacy and meet the eligibility requirements in the candidate handbook, implements policies and procedures for these certification programs, and oversees the development of the certification examination(s). The SPCB retains autonomy over all certification program policies and decisions. It is important to note that as the CSP’s governing board, the SPCB does not accredit, approve, endorse, or recommend any education or training programs and/or products designed or intended to prepare candidates for certification. SPCB has no involvement in the development or delivery of such programs or products.

Modified on December 01, 2023